Literature DB >> 28331468

Will Brivaracetam Help My Patient? Only Time Will Tell.

Jacqueline French.   

Abstract

Entities:  

Year:  2017        PMID： 28331468      PMCID： PMC5340554          DOI： 10.5698/1535-7511-17.1.35

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN： 1535-7511            Impact factor:   7.500


× No keyword cloud information.
  7 in total

Review 1.  Brivaracetam: Rationale for discovery and preclinical profile of a selective SV2A ligand for epilepsy treatment.

Authors:  Henrik Klitgaard; Alain Matagne; Jean-Marie Nicolas; Michel Gillard; Yves Lamberty; Marc De Ryck; Rafal M Kaminski; Karine Leclercq; Isabelle Niespodziany; Christian Wolff; Martyn Wood; Jonas Hannestad; Sophie Kervyn; Benoit Kenda
Journal:  Epilepsia       Date:  2016-02-26       Impact factor: 5.864

2.  A randomized, double-blind, placebo-controlled, multicenter, parallel-group study to evaluate the efficacy and safety of adjunctive brivaracetam in adult patients with uncontrolled partial-onset seizures.

Authors:  Pavel Klein; Jimmy Schiemann; Michael R Sperling; John Whitesides; Wei Liang; Tracy Stalvey; Christian Brandt; Patrick Kwan
Journal:  Epilepsia       Date:  2015-10-16       Impact factor: 5.864

3.  An open-label, prospective, exploratory study of patients with epilepsy switching from levetiracetam to brivaracetam.

Authors:  Stephen L Yates; Toufic Fakhoury; Wei Liang; Klaus Eckhardt; Simon Borghs; Joseph D'Souza
Journal:  Epilepsy Behav       Date:  2015-09-29       Impact factor: 2.937

4.  A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsy.

Authors:  T Betts; T Waegemans; P Crawford
Journal:  Seizure       Date:  2000-03       Impact factor: 3.184

Review 5.  Efficacy and tolerability of brivaracetam compared to lacosamide, eslicarbazepine acetate, and perampanel as adjunctive treatments in uncontrolled focal epilepsy: Results of an indirect comparison meta-analysis of RCTs.

Authors:  Francesco Brigo; Nicola Luigi Bragazzi; Raffaele Nardone; Eugen Trinka
Journal:  Seizure       Date:  2016-09-24       Impact factor: 3.184

Review 6.  Brivaracetam for the treatment of epilepsy.

Authors:  Pavel Klein; Ivana Tyrlikova; Milan Brazdil; Ivan Rektor
Journal:  Expert Opin Pharmacother       Date:  2016-01-13       Impact factor: 3.889

7.  Efficacy and safety of brivaracetam for partial-onset seizures in 3 pooled clinical studies.

Authors:  Elinor Ben-Menachem; Rūta Mameniškienė; Pier Paolo Quarato; Pavel Klein; Jessica Gamage; Jimmy Schiemann; Martin E Johnson; John Whitesides; Belinda McDonough; Klaus Eckhardt
Journal:  Neurology       Date:  2016-06-22       Impact factor: 9.910
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.